Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
RNAi in Drug Discovery & Therapeutics
Combining Tools and Technologies to Improve Delivery and Efficacy of Key Compounds
- The fledgling science of RNAi is making strides to take its place not only as a powerful therapeutic but also as a dynamic tool to increase the speed and efficiency of target validation and drug discovery. New advances will be highlighted at the upcoming Cambridge Healthtech Institute’s “RNAi: From ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.